MORNING RECAP 🔸 EVgo Inc ( $EVGO) launches secondary offering of 23 million Class A shares. 🔸 Mama's Creations ( $MAMA) Q3: EPS $0.01 (est. $0.04), adj. EBITDA $1.7M (est. $3.229M), revenue $31.5M (est. $30.05M). 🔸 McCormick ( $MKC) reportedly negotiating to acquire Sauer brands for $1 billion. 🔸 RCI Hospitality ( $RICK) Q4: adj. EPS $1.63 (est. $0.37), adj. EBITDA $17.9M (est. $13.92M), revenue $73.2M (est. $72.98M); forecasts FY29 revenue at $400M, FCF at $75M with 7.5M shares. 🔸 Tesla ( $TSLA) upgraded to Overweight by Mizuho, target price raised to $515. 🔸 Online sports betting: New Jersey's November handle exceeds $1.2B, with $119M in revenue, up 24.1% from last year. 🔸 Compass Minerals ( $CMP) Q4: adj. EPS loss (-$0.77) vs. est. (-$0.44), revenue $208.8M vs. est. $213.5M; adj. EBITDA $15.6M. 🔸 Expects 2025 salt sales volumes up 9% and 2024 Plant Nutrition volumes up 25% to 273K tons. 🔸 Kosmos Energy ( $KOS) abandons acquisition talks with Tullow Oil. 🔸 Joby Aviation ( $JOBY) completes major FAA certification tests for aerostructures. 🔸 Nucor Corp. ( $NUE) lowers Q4 EPS guidance to $0.55-$0.65, below consensus of $0.87. 🔸 Owens Corning ( $OC) upgraded to Overweight by Wells Fargo. 🔸 Biden administration offers PG&E ( $PCG) a $15B loan for climate and grid improvement projects. 🔸 Affirm Holdings ( $AFRM) issues $750M in Convertible Senior Notes due 2029, plans to repurchase up to $300M in Class A stock. 🔸 Marqeta ( $MQ) downgraded to Equal Weight by Barclays. 🔸 Jazz Pharmaceuticals ( $JAZZ) CEO Bruce Cozadd to retire by end of 2025. 🔸 Rockwell Medical ( $RMTI) secures multi-year deal with top dialysis provider, anticipating $10M+ in 2025 sales, with annual price increases and a term up to five years. 🔸 eBay Inc ( $EBAY) board approved an additional $3B for stock repurchases on Dec 12. 🔸 Mitek Systems ( $MITK) Q4: adj. EPS $0.33 (est. $0.17), adj. EBITDA $15.4M (est. $8.314M), revenue $43.222M (est. $41.31M); FY25 guidance: revenue $170-180M (est. $179.52M), adj. EBITDA margin 24-28%.

MORNING RECAP Tesla ( $TSLA): China-made EV sales dropped 4.3% y/y to 78,856 in November. Month-over-month increase of 15.5% for Model 3 and Model Y deliveries. Kroger ( $KR): Upgraded to Buy from Hold by Jefferies, target raised to $73 from $54. Downgraded by BMO Capital, target unchanged at $60. Live Nation Entertainment ( $LYV): Launched $1B in convertible senior notes due 2030. Axon (AXON): Upgraded to Overweight from Equal Weight by Morgan Stanley; target raised to $700 from $500. Crane Company (CR): Agreed to sell engineered materials segment for $227M to KPS Capital Partners, LP. Forecasts Q4 adjusted EPS from continuing operations at $1.10-$1.25. Donaldson (DCI): Q1 adjusted EPS $0.83, slightly above estimate of $0.82; Q1 revenue $900.1M vs. $892.43M expected. Maintains FY25 EPS guidance at $3.56-$3.72; expects revenue growth of 2%-6%. FedEx ( $FDX): Downgraded to Market Perform from Outperform at Bernstein; target reduced to $316 from $337. General Motors ( $GM): Non-binding agreement to sell stake in Ultium Cells LLC plant in Lansing to LG Energy Solutions. Honeywell ( $HON): Signed agreement with Bombardier for next-gen aviation tech; updated 2024 outlook. Joby Aviation Inc ( $JOBY): CFO Matthew Field to resign effective December 13, 2024. Rayonier ( $RYN): Authorized $300M share repurchase; announced special dividend of $1.80 per share. United States Steel ( $X): Shares fell after Trump's comments on reviving U.S. Steel and opposing Nippon Steel's acquisition. Aflac ( $AFL): Quarterly dividend increased by 16% to $0.58 per share. CleanSpark Inc. ( $CLSK): FY revenue at $378.9M, below estimates of $397.32M. Adjusted EBITDA at $245.8M, significantly above estimates of $141.44M. Regional Management Corp ( $RM): Announced a $30M stock repurchase program. State Street ( $STT): Upgraded to Outperform from Market Perform by Keefe Bruyette; target price raised to $120. PTC Therapeutics ( $PTCT): Upgraded to Outperform from Sector Perform by RBC Capital; target price increased to $63 from $39, citing transformative deal with Novartis. TransMedics ( $TMDX): Narrowed FY24 revenue guidance to $428M-$432M from $425M-$445M. Announced new CFO, Gerardo Hernandez, replacing Stephen Gordon. Vaxart ( $VXRT): Completed enrollment for sentinel cohort in phase 2B study of its COVID-19 oral vaccine candidate. Microchip Technology ( $MCHP): Shares fell after lowering December 2024 revenue guidance to about $1.025B. Announced closure of Tempe wafer fabrication facility (Fab 2). Microsoft ( $MSFT): Facing a £1 billion dispute in the U.K. over cloud software licensing practices. AT&T ( $T): Authorized $10B in share repurchases. Raised FY adjusted EPS guidance to $2.20-$2.25. Maintained free cash flow and capital expenditure forecasts. Credo Technology ( $CRDO): Q2 revenue $72.0M, above estimates; EPS $0.07 vs. $0.05 expected. Forecasts Q3 gross margin between 60.6%-62.6%; revenue guidance $115M-$125M. Bill Holdings ( $BILL): Offering $1.0B in convertible senior notes due 2030. Ingram Micro ( $INGM): To reduce workforce by 850 associates. IonQ ( $IONQ): Launched IonQ Quantum OS and IonQ Hybrid Services suite to enhance quantum computing utility. Seagate Technologies ( $STX): Expects lower production output for fiscal Q3 2025, impacting revenue by up to $200M. Zscaler ( $ZS): Q1 adjusted EPS $0.77, above $0.63 estimate; revenue $627.955M vs. $606.19M expected. Provided Q2 and FY revenue and EPS guidance, both exceeding consensus estimates.

$JOBY - JOBY RECEIVES FAA APPROVAL FOR PART 141 FLIGHT ACADEMY

$JOBY - JOBY AVIATION SHARES FALL 15% AFTER COMPANY PRICES STOCK SALE

$JOBY - TOYOTA TO INVEST $500 MILLION IN JOBY AVIATION